{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:11:01Z","timestamp":1758597061170,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.surg.2020.11.020","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T07:26:15Z","timestamp":1608967575000},"page":"1213-1220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei"],"prefix":"10.1016","volume":"169","author":[{"given":"Hayemin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae Youn","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2020.11.020_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4143\/crt.2014.46.2.124","article-title":"Prediction of cancer incidence and mortality in Korea, 2014","volume":"46","author":"Jung","year":"2014","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.surg.2020.11.020_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4143\/crt.2014.46.2.109","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011","volume":"46","author":"Jung","year":"2014","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.surg.2020.11.020_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/scbi.2001.0416","article-title":"Critical determinants of metastasis","volume":"12","author":"Fidler","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.surg.2020.11.020_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.surg.2020.11.020_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10120-005-0320-0","article-title":"Molecular-pathological prognostic factors of gastric cancer: a review","volume":"8","author":"Yasui","year":"2005","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.surg.2020.11.020_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2001-1326-3-17","article-title":"Clinical significance of epithelial-mesenchymal transition","volume":"3","author":"Steinestel","year":"2014","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.surg.2020.11.020_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5493\/wjem.v5.i2.84","article-title":"Role of the Wnt\/beta-catenin pathway in gastric cancer: An in-depth literature review","volume":"5","author":"Chiurillo","year":"2015","journal-title":"World J Exp Med"},{"key":"10.1016\/j.surg.2020.11.020_bib8","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3892\/ijo.2016.3480","article-title":"Interaction between Wnt\/beta-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (review)","volume":"48","author":"Wu","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.surg.2020.11.020_bib9","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1158\/1078-0432.CCR-16-2180","article-title":"HMGA2-FOXL2 axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer","volume":"23","author":"Dong","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2020.11.020_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3892\/or.2016.5255","article-title":"HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer","volume":"37","author":"Li","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.surg.2020.11.020_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.12659\/MSM.898740","article-title":"MicroRNA-495 inhibits gastric cancer cell migration and invasion possibly via targeting high mobility group at-hook 2 (HMGA2)","volume":"23","author":"Wang","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.surg.2020.11.020_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12935-019-0875-1","article-title":"MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway","volume":"19","author":"Li","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.surg.2020.11.020_bib13","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1016\/S0021-9258(19)38926-4","article-title":"The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure","volume":"265","author":"Reeves","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.surg.2020.11.020_bib14","first-page":"775","article-title":"HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors","volume":"149","author":"Rogalla","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.surg.2020.11.020_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2004.08.013","article-title":"Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer","volume":"574","author":"Sgarra","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.surg.2020.11.020_bib16","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1158\/1078-0432.CCR-07-4667","article-title":"Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family","volume":"14","author":"Motoyama","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2020.11.020_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12032-014-0130-5","article-title":"Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer","volume":"31","author":"Kong","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.surg.2020.11.020_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijsu.2015.10.031","article-title":"HMGA1\/HMGA2 protein expression and prognostic implications in gastric cancer","volume":"24","author":"Jun","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.surg.2020.11.020_bib19","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3892\/ijo.2015.2947","article-title":"High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition","volume":"46","author":"Lee","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.surg.2020.11.020_bib20","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/cas.13288","article-title":"High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression","volume":"108","author":"Chung","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.surg.2020.11.020_bib21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.29539","article-title":"Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer","volume":"137","author":"Chung","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2020.11.020_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2020.11.020_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAI.0b013e31821c821c","article-title":"HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment","volume":"20","author":"Kunz","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.surg.2020.11.020_bib24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3346\/jkms.2006.21.5.871","article-title":"Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer","volume":"21","author":"Joo","year":"2006","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.surg.2020.11.020_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/cgt.2014.55","article-title":"Knockdown of EGFR inhibits growth and invasion of gastric cancer cells","volume":"21","author":"Zhen","year":"2014","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.surg.2020.11.020_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cam4.346","article-title":"Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer","volume":"4","author":"Ando","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.surg.2020.11.020_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pathophys.2017.02.006","article-title":"Immunohistochemical analysis of PTEN, HER2\/neu, and ki67 expression in patients with gastric cancer and their association with survival","volume":"24","author":"Badary","year":"2017","journal-title":"Pathophysiology"},{"key":"10.1016\/j.surg.2020.11.020_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","article-title":"Assessment of a HER2 scoring system for gastric cancer: results from a validation study","volume":"52","author":"Hofmann","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.surg.2020.11.020_bib29","doi-asserted-by":"crossref","first-page":"100478","DOI":"10.18632\/oncotarget.19001","article-title":"Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.surg.2020.11.020_bib30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.18632\/oncotarget.23085","article-title":"High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis","volume":"9","author":"Nie","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.surg.2020.11.020_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-013-0252-z","article-title":"HER2-positive gastric cancer","volume":"17","author":"Boku","year":"2014","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.surg.2020.11.020_bib32","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","article-title":"HER2 testing in gastric cancer: An update","volume":"22","author":"Abrahao-Machado","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2020.11.020_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.21873\/anticanres.13958","article-title":"Role of COX2 as a biomarker for estimating survival of patients with clinical stage I gastric cancer","volume":"40","author":"Yoo","year":"2020","journal-title":"Anticancer Res"},{"year":"2000","series-title":"Applied Logistic Regression","author":"Hosmer","key":"10.1016\/j.surg.2020.11.020_bib34"},{"key":"10.1016\/j.surg.2020.11.020_bib35","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1349-7006.2009.01260.x","article-title":"Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells","volume":"100","author":"Kim","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.surg.2020.11.020_bib36","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1158\/0008-5472.CAN-08-4312","article-title":"Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2020.11.020_bib37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/15680096113136660097","article-title":"Roles of epithelial-mesenchymal transition in cancer drug resistance","volume":"13","author":"Shang","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.surg.2020.11.020_bib38","first-page":"260","article-title":"HMGA2 regulates CD44 expression to promote gastric\u00a0cancer cell motility and sphere formation","volume":"7","author":"Sun","year":"2017","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.surg.2020.11.020_bib39","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","article-title":"Molecular mechanisms of peritoneal dissemination in gastric cancer","volume":"22","author":"Kanda","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2020.11.020_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/PL00011698","article-title":"Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer","volume":"3","author":"Yonemura","year":"2000","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.surg.2020.11.020_bib41","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/DDDT.S75429","article-title":"The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review","volume":"9","author":"Zeng","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.surg.2020.11.020_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2019.04.034","article-title":"Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer","volume":"457","author":"Hu","year":"2019","journal-title":"Cancer Lett"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606020308059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606020308059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:57:59Z","timestamp":1758538679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606020308059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0039606020308059"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2020.11.020","relation":{},"ISSN":["0039-6060"],"issn-type":[{"type":"print","value":"0039-6060"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2020.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}